BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23999075)

  • 1. Kidins220/ARMS is expressed in neuroblastoma tumors and stabilizes neurotrophic signaling in a human neuroblastoma cell line.
    Rogers DA; Schor NF
    Pediatr Res; 2013 Nov; 74(5):517-24. PubMed ID: 23999075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidins220/ARMS depletion is associated with the neural-to Schwann-like transition in a human neuroblastoma cell line model.
    Rogers DA; Schor NF
    Exp Cell Res; 2013 Mar; 319(5):660-9. PubMed ID: 23333500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ankyrin repeat-rich membrane spanning (ARMS)/Kidins220 scaffold protein regulates neuroblastoma cell proliferation through p21.
    Jung H; Shin JH; Park YS; Chang MS
    Mol Cells; 2014 Dec; 37(12):881-7. PubMed ID: 25410904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidins220 accumulates with tau in human Alzheimer's disease and related models: modulation of its calpain-processing by GSK3β/PP1 imbalance.
    López-Menéndez C; Gamir-Morralla A; Jurado-Arjona J; Higuero AM; Campanero MR; Ferrer I; Hernández F; Ávila J; Díaz-Guerra M; Iglesias T
    Hum Mol Genet; 2013 Feb; 22(3):466-82. PubMed ID: 23118350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a neuroprotective peptide that preserves survival pathways by preventing Kidins220/ARMS calpain processing induced by excitotoxicity.
    Gamir-Morralla A; López-Menéndez C; Ayuso-Dolado S; Tejeda GS; Montaner J; Rosell A; Iglesias T; Díaz-Guerra M
    Cell Death Dis; 2015 Oct; 6(10):e1939. PubMed ID: 26492372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidins220/ARMS mediates the integration of the neurotrophin and VEGF pathways in the vascular and nervous systems.
    Cesca F; Yabe A; Spencer-Dene B; Scholz-Starke J; Medrihan L; Maden CH; Gerhardt H; Orriss IR; Baldelli P; Al-Qatari M; Koltzenburg M; Adams RH; Benfenati F; Schiavo G
    Cell Death Differ; 2012 Feb; 19(2):194-208. PubMed ID: 22048155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidins220/ARMS is transported by a kinesin-1-based mechanism likely to be involved in neuronal differentiation.
    Bracale A; Cesca F; Neubrand VE; Newsome TP; Way M; Schiavo G
    Mol Biol Cell; 2007 Jan; 18(1):142-52. PubMed ID: 17079733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidins220/ARMS associates with B-Raf and the TCR, promoting sustained Erk signaling in T cells.
    Deswal S; Meyer A; Fiala GJ; Eisenhardt AE; Schmitt LC; Salek M; Brummer T; Acuto O; Schamel WW
    J Immunol; 2013 Mar; 190(5):1927-35. PubMed ID: 23359496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuronal protein Kidins220/ARMS associates with ICAM-3 and other uropod components and regulates T-cell motility.
    Jean-Mairet RM; López-Menéndez C; Sánchez-Ruiloba L; Sacristán S; Rodríguez-Martínez M; Riol-Blanco L; Sánchez-Mateos P; Sánchez-Madrid F; Rodríguez-Fernández JL; Campanero MR; Iglesias T
    Eur J Immunol; 2011 Apr; 41(4):1035-46. PubMed ID: 21381019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death.
    Li Z; Zhang J; Liu Z; Woo CW; Thiele CJ
    Cell Death Differ; 2007 Feb; 14(2):318-26. PubMed ID: 16778834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal transduction pathways through TRK-A and TRK-B receptors in human neuroblastoma cells.
    Sugimoto T; Kuroda H; Horii Y; Moritake H; Tanaka T; Hattori S
    Jpn J Cancer Res; 2001 Feb; 92(2):152-60. PubMed ID: 11223544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidins220/ARMS Expression Confers Proliferation But Independent of Self-Renewal in Mouse Embryonic Stem Cells.
    Luo J; Zhou Y; Chen Q; Zhao X; Zhang M
    Cell Reprogram; 2018 Dec; 20(6):365-370. PubMed ID: 31251671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of BDNF Release by ARMS/Kidins220 through Modulation of Synaptotagmin-IV Levels.
    López-Benito S; Sánchez-Sánchez J; Brito V; Calvo L; Lisa S; Torres-Valle M; Palko ME; Vicente-García C; Fernández-Fernández S; Bolaños JP; Ginés S; Tessarollo L; Arévalo JC
    J Neurosci; 2018 Jun; 38(23):5415-5428. PubMed ID: 29769266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a switch in neurotrophin signaling by selective tyrosine phosphorylation.
    Arévalo JC; Pereira DB; Yano H; Teng KK; Chao MV
    J Biol Chem; 2006 Jan; 281(2):1001-7. PubMed ID: 16284401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and function of TRK-B and BDNF in human neuroblastomas.
    Nakagawara A; Azar CG; Scavarda NJ; Brodeur GM
    Mol Cell Biol; 1994 Jan; 14(1):759-67. PubMed ID: 8264643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinase D-interacting Substrate of 220 kDa Is Overexpressed in Gastric Cancer and Associated With Local Invasion.
    Cai S; Sun Z; Gao X; Ji KE; Ruge F; Shankla D; Liu X; Jiang WG; Ye L
    Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):735-743. PubMed ID: 38035704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidins220 and tumour development: Insights into a complexity of cross-talk among signalling pathways (Review).
    Cai S; Cai J; Jiang WG; Ye L
    Int J Mol Med; 2017 Oct; 40(4):965-971. PubMed ID: 28849114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A developmental stage- and Kidins220-dependent switch in astrocyte responsiveness to brain-derived neurotrophic factor.
    Jaudon F; Albini M; Ferroni S; Benfenati F; Cesca F
    J Cell Sci; 2021 Aug; 134(16):. PubMed ID: 34279618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells.
    Matsumoto K; Wada RK; Yamashiro JM; Kaplan DR; Thiele CJ
    Cancer Res; 1995 Apr; 55(8):1798-806. PubMed ID: 7712490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced kinase D‑interacting substrate of 220 kDa (Kidins220) in pancreatic cancer promotes EGFR/ERK signalling and disease progression.
    Cai S; Sun Z; Sun PH; Gao X; Ji K; Tian X; Ji J; Hao C; Soliman F; Liu C; Al-Sarireh B; Griffiths P; Hiscox S; Jiang WG; Ye L
    Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33955519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.